Halberd Corporation
HALB
Rank in Stocks
#32762
Halberd Corporation is a biotechnology firm dedicated to pioneering therapies... Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions. The company's therapeutic focus encompasses a broad range of serious illnesses, including post-traumatic stress disorder (PTSD) and chronic traumatic encephalopathy (CTE), Alzheimer's disease, Parkinson's disease, various forms of cancer, and disorders impacting the blood and cerebrospinal fluid. Established in 2009, Halberd Corporation operates from its headquarters in Jackson Center, Pennsylvania.
Share Price
$0.0016
Last synced: 2026-11-18
Market Cap
$1.13M
Change (1 day)
-2.44%
Change (1 year)
15.94%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Halberd Corporation (HALB)
Category
Healthcare
Earnings for Halberd Corporation (HALB)
Earnings in Jan 2026 TTM: $-44.49K
According to Halberd Corporation's latest financial reports, its current earnings (TTM) are $-44.49K. In 2025 the company earned $-20.07K, an increase over its 2024 earnings of $-79.68K. The earnings shown on this page are earnings before interest and taxes, or EBIT.
Earnings history for Halberd Corporation from 2008 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $-44.49K | 121.67% |
| 2025 | $-20.07K | -74.81% |
| 2024 | $-79.68K | -82.45% |
| 2023 | $-454.07K | -72.05% |
| 2022 | $-1.62M | 88.59% |
| 2021 | $-861.54K | -47.60% |
| 2020 | $-1.64M | 7,400.68% |
| 2019 | $-21.92K | 54.05% |
| 2018 | $-14.23K | -95.91% |
| 2017 | $-348.00K | -1,119.60% |
| 2016 | $34.13K | -113.44% |
| 2015 | $-254.00K | -51.80% |
| 2014 | $-527.00K | 149.76% |
| 2013 | $-211.00K | -615.02% |
| 2012 | $40.97K | -77.34% |
| 2011 | $180.81K | -155.81% |
| 2010 | $-324.00K | -72.77% |
| 2009 | $-1.19M | 2,127.42% |
| 2008 | $-53.43K | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $4.76B | -10,697,769.19% |
US
|
|
| $-2.73B | 6,133,724.82% |
US
|
|
| $-4.02B | 9,026,886.25% |
AU
|
|
| $2.79B | -6,278,592.11% |
BE
|
|
| $1.50B | -3,364,695.31% |
NL
|
Questions about Halberd Corporation's net income
What is Halberd Corporation's net income?
Halberd Corporation's net income over the last twelve months is $-44.49K, as of Jan 2026.
What was Halberd Corporation's net income in 2025?
In 2025, Halberd Corporation's net income was $-20.07K, compared with $-79.68K in 2024.
How has Halberd Corporation's net income changed since 2020?
From 2020 to 2025, Halberd Corporation's net income was highest in 2025 ($-20.07K) and lowest in 2020 ($-1.64M).
How does Halberd Corporation's net income compare with similar companies?
Halberd Corporation's net income ($-44.49K) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $4.76B.